 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This is a signal that OSUR's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

OraSure Technologies (OSUR, $6.14) RSI Indicator left the oversold zone on March 27, 2024

OraSure Technologies (OSUR, $6.09) RSI Indicator left the oversold zone on March 26, 2024

This is a Bearish indicator signaling OSUR's price could decline from here. Traders may explore shorting the stock or put options...

OraSure Technologies (OSUR, $6.68) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 15, 2024

This price move could indicate a change in the trend, and may be a sell signal for investors...

OraSure Technologies (OSUR, $7.2) price exceeded its 50-day Moving Average on February 29, 2024

OraSure Technologies, Inc. (OSUR) Q4 2023 Earnings Call Transcript...

OraSure Technologies, Inc. (OSUR) Q4 2023 Earnings Call Transcript

In recent trading, shares of OraSure Technologies Inc. (OSUR) have crossed above the average analyst 12-month target price of 7.00, changing hands for 7.01/share...

OSUR Crosses Above Average Analyst Target

Company Sees Decrease in COVID-19 Revenue but Maintains Core Business StabilityRelated Stocks: OSUR...

OraSure Technologies Inc (OSUR) Reports Q4 Revenue Decline Amidst Strategic Growth Efforts

Q4 GAAP EPS of $0.27; Q4 Non-GAAP EPS of $0.22 Grew cash balance to $290.4 million as of December 31, 2023 Enters U.S. Syphilis testing market via strategic distribution agreement with Diagnostics...

OraSure Reports Q4 '23 Revenue of $75.9 Million

OraSure Technologies (OSUR, $6.82) RSI Indicator left the oversold zone on February 20, 2024

BETHLEHEM, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2023 financial results and...

OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.

Volume (M)	8.00
52-Wk High	$8.45
52-Wk Low	$4.38

OSUR Orasure Technologies Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals